| Metric | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 6.5M +15.0% | 5.7M -21.5% | 7.2M -7.5% | 7.8M +15.1% | 6.8M |
| R&D | 4.4M +13.8% | 3.8M -28.9% | 5.4M -3.4% | 5.6M +8.9% | 5.1M |
| SG&A | 2.2M +17.6% | 1.8M +0.2% | 1.8M -17.8% | 2.2M +33.9% | 1.7M |
| Operating Income | -6538000 -15.0% | -5683000 +21.5% | -7244000 +7.5% | -7829000 -15.1% | -6804000 |
| EBITDA | -6037000 -15.2% | -5242000 +23.1% | -6814000 +8.4% | -7438000 -16.3% | -6394000 |
| Net Income | -6486000 -1.5% | -6390000 +13.2% | -7360000 +5.5% | -7790000 -16.2% | -6702000 |
| EPS (Basic) | $-1.19 | — | $-3.30 +21.4% | $-4.20 -13.5% | $-3.70 |
| EPS (Diluted) | $-1.19 | — | $-3.30 +21.4% | $-4.20 -13.5% | $-3.70 |
| Shares (Diluted) | 5.5M | — | 2.2M +18.6% | 1.9M +2.3% | 1.8M |